Shi, Yanshu
Zhang, Linzixuan
Chen, Min
Calle, Elizabeth A.
Langer, Robert
Article History
Received: 3 February 2025
Revised: 16 August 2025
Accepted: 3 September 2025
First Online: 13 October 2025
Declarations
:
: Not applicable
: From FY 2020 to the present, Dr. Robert Langer receives licensing fees (to patents in which he was an inventor on) from, invested in, consults (or was on Scientific Advisory Boards or Boards of Directors) for, lectured (and received a fee), or conducts sponsored research at MIT for which he was not paid for the following entities: . EAC is an inventor on patents that are licensed to United Therapeutics and that produce royalties for EAC. The other authors declare no competing interests.
Free to read: This content has been made available to all.